G13 Controls Angiogenesis through Regulation of VEGFR-2 Expression

Developmental Cell

Volumn 25, Issue 4, 2013, Pages 427-434

  Sivaraj, KishorKumar ^a   Takefuji, Mikito ^a   Schmidt, Inga ^b   Adams, RalfH ^b,c   Offermanns, Stefan ^a,d   Wettschureck, Nina ^a,d  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TAMOXIFEN; VASCULOTROPIN RECEPTOR 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MEMBRANE BOUND TRANSCRIPTION FACTOR PEPTIDASE, SITE 1; MEMBRANE-BOUND TRANSCRIPTION FACTOR PEPTIDASE, SITE 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, MOUSE; SERINE PROTEINASE; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ALLELE; ANIMAL; C57BL MOUSE; DRUG EFFECT; ENDOTHELIUM; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROMOTER REGION; RETINA; RETINA BLOOD VESSEL; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

MUS;

ALLELES; ANIMALS; CELL LINE, TUMOR; ENDOTHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUNG; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROPROTEIN CONVERTASES; RETINA; RETINAL VESSELS; RHO GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; TAMOXIFEN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MLCS; MLOWN;

EID: 84878362932     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2013.04.008     Document Type: Article

References (33)

1. Abumiya T., Sasaguri T., Taba Y., Miwa Y., Miyagi M. Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site. Arterioscler. Thromb. Vasc. Biol. 2002, 22:907-913.
2. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
3. Brown J.H., Del Re D.P., Sussman M.A. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ. Res. 2006, 98:730-742.
4. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
5. Chen L., Zhang J.J., Rafii S., Huang X.Y. Suppression of tumor angiogenesis by Galpha(13) haploinsufficiency. J.Biol. Chem. 2009, 284:27409-27415.
6. Connolly A.J., Ishihara H., Kahn M.L., Farese R.V., Coughlin S.R. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996, 381:516-519.
7. Dorsam R.T., Gutkind J.S. G-protein-coupled receptors and cancer. Nat. Rev. Cancer 2007, 7:79-94.
8. Gariano R.F., Gardner T.W. Retinal angiogenesis in development and disease. Nature 2005, 438:960-966.
9. Heidenreich R., Kappel A., Breier G. Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences. Cancer Res. 2000, 60:6142-6147.
10. Illi B., Puri P., Morgante L., Capogrossi M.C., Gaetano C. Nuclear factor-kappaB and cAMP response element binding protein mediate opposite transcriptional effects on the Flk-1/KDR gene promoter. Circ. Res. 2000, 86:E110-E117.
11. Jakobsson L., Franco C.A., Bentley K., Collins R.T., Ponsioen B., Aspalter I.M., Rosewell I., Busse M., Thurston G., Medvinsky A., et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 2010, 12:943-953.
12. Korhonen H., Fisslthaler B., Moers A., Wirth A., Habermehl D., Wieland T., Schütz G., Wettschureck N., Fleming I., Offermanns S. Anaphylactic shock depends on endothelial Gq/G11. J.Exp. Med. 2009, 206:411-420.
13. Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009, 21:154-165.
14. Mammoto A., Connor K.M., Mammoto T., Yung C.W., Huh D., Aderman C.M., Mostoslavsky G., Smith L.E., Ingber D.E. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009, 457:1103-1108.
15. Mandriota S.J., Menoud P.A., Pepper M.S. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J.Biol. Chem. 1996, 271:11500-11505.
16. Martin C.B., Mahon G.M., Klinger M.B., Kay R.J., Symons M., Der C.J., Whitehead I.P. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 2001, 20:1953-1963.
17. Millauer B., Wizigmann-Voos S., Schnürch H., Martinez R., Møller N.P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846.
18. Murakami M., Nguyen L.T., Hatanaka K., Schachterle W., Chen P.Y., Zhuang Z.W., Black B.L., Simons M. FGF-dependent regulation of VEGF receptor 2 expression in mice. J.Clin. Invest. 2011, 121:2668-2678.
19. Obinata H., Hla T. Sphingosine 1-phosphate in coagulation and inflammation. Semin. Immunopathol. 2012, 34:73-91.
20. Offermanns S., Mancino V., Revel J.P., Simon M.I. Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 1997, 275:533-536.
21. Patterson C., Perrella M.A., Hsieh C.M., Yoshizumi M., Lee M.E., Haber E. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J.Biol. Chem. 1995, 270:23111-23118.
22. Pitulescu M.E., Schmidt I., Benedito R., Adams R.H. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 2010, 5:1518-1534.
23. Profirovic J., Gorovoy M., Niu J., Pavlovic S., Voyno-Yasenetskaya T. A novel mechanism of G protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein. J.Biol. Chem. 2005, 280:32866-32876.
24. Richard D.E., Vouret-Craviari V., Pouysségur J. Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 2001, 20:1556-1562.
25. Ruppel K.M., Willison D., Kataoka H., Wang A., Zheng Y.W., Cornelissen I., Yin L., Xu S.M., Coughlin S.R. Essential role for Galpha13 in endothelial cells during embryonic development. Proc. Natl. Acad. Sci. USA 2005, 102:8281-8286.
26. Sainson R.C., Johnston D.A., Chu H.C., Holderfield M.T., Nakatsu M.N., Crampton S.P., Davis J., Conn E., Hughes C.C. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008, 111:4997-5007.
27. Shan D., Chen L., Wang D., Tan Y.C., Gu J.L., Huang X.Y. The G protein G alpha(13) is required for growth factor-induced cell migration. Dev. Cell 2006, 10:707-718.
28. Shibuya M., Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 2006, 312:549-560.
29. Skoura A., Sanchez T., Claffey K., Mandala S.M., Proia R.L., Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J.Clin. Invest. 2007, 117:2506-2516.
30. Tsopanoglou N.E., Maragoudakis M.E. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J.Biol. Chem. 1999, 274:23969-23976.
31. Urbich C., Stein M., Reisinger K., Kaufmann R., Dimmeler S., Gille J. Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding. FEBS Lett. 2003, 535:87-93.
32. Worzfeld T., Wettschureck N., Offermanns S. G(12)/G(13)-mediated signalling in mammalian physiology and disease. Trends Pharmacol. Sci. 2008, 29:582-589.
33. Zhang N., Fang Z., Contag P.R., Purchio A.F., West D.B. Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood 2004, 103:617-626.